Form 4: SeaStar Medical Director Awarded 3,000 RSUs

SeaStar Medical Holding Corp Director Kenneth Van Heel was granted 3,000 Restricted Stock Units, vesting fully on February 6, 2027.

Summary

• Kenneth Van Heel, a Director of SeaStar Medical Holding Corp (ICU), was granted 3,000 shares of common stock.
• The transaction occurred on February 6, 2026, and the shares were acquired at a price of $0.
• These shares represent a Restricted Stock Unit (RSU) award.
• The RSUs will vest in full on February 6, 2027.
• Following this transaction, Mr. Van Heel beneficially owns 7,940 shares of common stock.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, as it represents a standard compensation practice that aligns director interests with long-term company performance, without indicating any immediate operational changes or financial distress.

Positives

• The RSU award aligns the director's interests with long-term shareholder value.
• Granting equity compensation is a common practice to incentivize and retain key personnel.

Future Outlook

The RSU award is structured to vest in the future (February 6, 2027), indicating a long-term incentive for the director.

Industry Context

StockSavvy.ai notes that equity compensation, such as RSU awards, is a standard practice across various industries, particularly in the biotechnology and medical device sectors where long-term development cycles necessitate retaining experienced leadership. This aligns SeaStar Medical with common industry compensation strategies for directors.

Comparison to Industry Standards

• The granting of RSUs to directors is a common compensation practice, comparable to companies like Medtronic (MDT) or Boston Scientific (BSX) which frequently use equity awards to align director interests with shareholder value.
• The vesting schedule (full vesting after one year) is a typical structure for director equity awards, often designed to encourage continued service and strategic oversight.

Related Party Transactions

• Grant of 3,000 Restricted Stock Units (RSUs) to Kenneth Van Heel, a Director, as part of his compensation.

Stakeholder Impact

• Shareholders: The RSU award aligns the director's interests with shareholder value, potentially leading to better long-term decision-making. It also represents a minimal dilution potential upon vesting.

Next Steps

• The RSUs granted to Kenneth Van Heel are scheduled to vest in full on February 6, 2027.

Key Dates

Recommendation

This Form 4 filing reports a routine equity compensation award to a director, which is a standard practice for aligning management and board interests with shareholders. It does not provide new information that would fundamentally alter the investment thesis for SeaStar Medical, hence a 'hold' recommendation is appropriate as it maintains the status quo.

Keywords

SeaStar Medical Holding Corp, ICU, Form 4, Restricted Stock Units, RSU, Director Compensation, Equity Award, Insider Transaction, Kenneth Van Heel